Skip to main content

Want a detailed portfolio tracker?

Palvella Therapeutics (PVLA) P/E (2024 - 2026)

Palvella Therapeutics (PVLA) P/E from Dec 16, 2024 to Jul 21, 2026. The TTM Palvella Therapeutics (PVLA) P/E is -130.65. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Palvella Therapeutics (PVLA)

YearP/EChange
2026-130.65+28.14%
2025-101.96+204.77%
2024-33.45N/A

Comparison Palvella Therapeutics (PVLA) P/E with competitors

Palvella Therapeutics (PVLA) P/E is -130.65.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.00%
NBYStablecoin Development Corp0.00-100.00%
ENLVEnlivex Ltd0.07-100.06%
FGENFibroGen Inc0.24-100.18%
CHRSCoherus Biosciences Inc0.85-100.65%
FBIOFortress Biotech Inc0.95-100.73%
ORMPOramed Pharmaceuticals Inc1.50-101.15%
AGENAgenus Inc3.01-102.30%
INVAInnoviva Inc3.15-102.41%
VXRTVaxart Inc3.55-102.72%
CRMDCorMedix Inc3.63-102.78%
CVACCureVac N.V.4.45-103.40%
GLPGGalapagos NV4.86-103.72%
SRPTSarepta Therapeutics Inc4.88-103.74%
ABEOAbeona Therapeutics Inc5.39-104.12%
ABUSArbutus Biopharma Corp5.60-104.28%
ZVRAZevra Therapeutics Inc5.89-104.51%
SPROSpero Therapeutics Inc6.23-104.77%
CGENCompugen Ltd6.31-104.83%
RIGLRigel Pharmaceuticals6.87-105.26%
SLXNSilexion Therapeutics Corp7.30-105.58%
OMEROmeros Corporation9.26-107.09%
AUPHAurinia Pharmaceuticals Inc9.58-107.34%
PLXProtalix BioTherapeutics Inc10.89-108.34%
ACADAcadia Pharmaceuticals Inc11.73-108.98%
TBPHTheravance Biopharma Inc12.26-109.39%
ADMAAdma Biologics Inc12.42-109.50%
HRMYHarmony Biosciences Holdings Inc13.82-110.58%
SABSSAB Biotherapeutics Inc14.14-110.82%
NAGENiagen Bioscience Inc14.82-111.34%
INCYIncyte Corp15.82-112.11%
REGNRegeneron Pharmaceuticals Inc15.86-112.14%
PBYIPuma Biotechnology Inc17.32-113.25%
CPRXCatalyst Pharmaceuticals Inc17.44-113.35%
EXELExelixis Inc17.54-113.42%
TGTXTG Therapeutics Inc18.97-114.52%
MDXGMimedx Group Inc20.55-115.73%
XOMAXOMA Royalty Corp22.87-117.51%
ARGXArgen X SE24.30-118.60%
CTMXCytomX Therapeutics Inc24.82-119.00%
XOMAOXOMA Royalty Corp25.34-119.40%
HALOHalozyme Therapeutics Inc25.62-119.61%
XOMAPXOMA Royalty Corp25.67-119.65%
VRTXVertex Pharmaceuticals Inc27.99-121.43%
RPRXRoyalty Pharma plc - Class A28.69-121.96%
SLNOSoleno Therapeutics Inc29.02-122.21%
ASNDAscendis Pharma A/S30.09-123.03%
LGNDLigand Pharmaceuticals Inc - Class B37.91-129.02%
APLSApellis Pharmaceuticals Inc39.02-129.87%
BMRNBiomarin Pharmaceutical Inc42.21-132.31%
KRYSKrystal Biotech Inc45.34-134.71%
ONCBeiGene Ltd69.54-153.23%
PHARPharming Group N.V.75.03-157.43%
TECHBio-Techne Corp101.96-178.04%
VCELVericel Corp109.92-184.14%
ALNYAlnylam Pharmaceuticals Inc117.96-190.29%
GMABGenmab140.29-207.38%
TLXTelix Pharmaceuticals Ltd162.15-224.11%
CORTCorcept Therapeutics Inc212.86-262.92%